BCL-2 inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCL-2 inhibitors, covering 2024-09-24 to 2024-09-24. Get the full timeline:
Most recent: Clinical Trial Update: BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma. [Phase 2]